http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08500107-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4745 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate | 1993-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1996-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08500107-A |
| titleOfInvention | Immunochemical assay for cancer-related SCM recognition factor |
| abstract | (57) [Summary] Disclosed are an antibody against a peptide (SCM factor peptide) active in the structure of a cytoplasmic matrix test and an antibody against a fragment of the peptide by immunizing an antibody-producing animal with the following peptide or fragment. . Polyclonal and monoclonal antibodies can be obtained. Particularly useful is the peptide M-I-P-P-E-V-K-F-N-K-P-F-V-F-L-M-I-D-Q-N-T-K-V. -P-L-F-M-G-K (SEQ ID NO: 2) and F-L-M-I-D-Q-N-T-K (SEQ ID NO: 3) are antibodies that specifically bind to each other. . The antibody can be labeled and is suitable for performing an immunoassay to detect the presence of the SCM cancer recognition factor in cell culture or body fluids. One particularly useful immunoassay is able to distinguish between partially homologous peptide sequences and SCM factors, and (a) a first aliquot of the sample is incubated with a first antibody specific for a cancer recognition factor. Binding a first antibody to a cancer recognition factor in the first aliquot; (b) adding a second aliquot of the sample to a second amino acid-specific portion of the partially homologous peptide sequence. Reacting with an antibody to bind a second antibody to a partially homologous peptide sequence in a second aliquot; and (c) an amount of the first antibody bound to the first aliquot to a second aliquot. A step of detecting the cancer recognition factor, as compared to the amount of the second antibody bound to the. |
| priorityDate | 1992-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 348.